Sex differences in nonmedical prescription tranquilizer and stimulant use trends among secondary school students in Argentina, Chile, and Uruguay.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 31 12 2018
revised: 31 07 2019
accepted: 01 08 2019
pubmed: 14 10 2019
medline: 1 7 2020
entrez: 14 10 2019
Statut: ppublish

Résumé

Little is known about recent nonmedical prescription tranquilizer and stimulant use trends in Latin America. We tested whether recent trends among students in three South American countries differed by sex over time. Three countries independently collected National School Students Survey on Drugs. Students in 8th, 10th, and 12th grades were sampled in Argentina (2007-2014, N = 328,202), Chile (2007-2015, N = 136,379), and Uruguay (2007-2016, N = 32,371). Weighted linear regression models predicted the prevalences and trends over time of past-year nonmedical tranquilizer and stimulant use by country, and tested whether trends differed by sex, adjusting for school type and grade. In Argentina from 2007 to 2014, past-year nonmedical prescription tranquilizer (girls: 2.8 to 2.6%, boys: 2.5 to 2.3%) and stimulant (girls: 1.7 to 1.3%, boys: 1.9 to 1.5%) use trends did not differ by sex. In Chile from 2007 to 2015, nonmedical prescription tranquilizer use trends significantly differed comparing girls (3.9 to 10%) with boys (3.2 to 6.9%); stimulant use trends did not differ comparing girls (1.6 to 2.0%) with boys (2.0 to 1.3%). In Uruguay from 2007 to 2014 and 2014-2016, past-year nonmedical prescription tranquilizer (girls: 5.1 to 6.6%; boys: 2.8 to 4.2%) and stimulant (girls: 1.8 to 0.7%; boys: 1.8 to 0.7%) use trends did not differ by sex. Trends of nonmedical prescription tranquilizer use recently increased in Chile and Uruguay, widening by sex over time in Chile only. The drivers of increasing tranquilizer use among girls in Chile and Uruguay merit further investigation.

Sections du résumé

BACKGROUND
Little is known about recent nonmedical prescription tranquilizer and stimulant use trends in Latin America. We tested whether recent trends among students in three South American countries differed by sex over time.
METHODS
Three countries independently collected National School Students Survey on Drugs. Students in 8th, 10th, and 12th grades were sampled in Argentina (2007-2014, N = 328,202), Chile (2007-2015, N = 136,379), and Uruguay (2007-2016, N = 32,371). Weighted linear regression models predicted the prevalences and trends over time of past-year nonmedical tranquilizer and stimulant use by country, and tested whether trends differed by sex, adjusting for school type and grade.
RESULTS
In Argentina from 2007 to 2014, past-year nonmedical prescription tranquilizer (girls: 2.8 to 2.6%, boys: 2.5 to 2.3%) and stimulant (girls: 1.7 to 1.3%, boys: 1.9 to 1.5%) use trends did not differ by sex. In Chile from 2007 to 2015, nonmedical prescription tranquilizer use trends significantly differed comparing girls (3.9 to 10%) with boys (3.2 to 6.9%); stimulant use trends did not differ comparing girls (1.6 to 2.0%) with boys (2.0 to 1.3%). In Uruguay from 2007 to 2014 and 2014-2016, past-year nonmedical prescription tranquilizer (girls: 5.1 to 6.6%; boys: 2.8 to 4.2%) and stimulant (girls: 1.8 to 0.7%; boys: 1.8 to 0.7%) use trends did not differ by sex.
CONCLUSIONS
Trends of nonmedical prescription tranquilizer use recently increased in Chile and Uruguay, widening by sex over time in Chile only. The drivers of increasing tranquilizer use among girls in Chile and Uruguay merit further investigation.

Identifiants

pubmed: 31606591
pii: S0376-8716(19)30384-9
doi: 10.1016/j.drugalcdep.2019.107607
pmc: PMC6943976
mid: NIHMS1545610
pii:
doi:

Substances chimiques

Central Nervous System Stimulants 0
Hypnotics and Sedatives 0
Tranquilizing Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

107607

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA045224
Pays : United States
Organisme : NIDA NIH HHS
ID : L30 DA042436
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA040924
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA031099
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Drug Alcohol Depend. 2019 Aug 1;201:115-126
pubmed: 31207452
Addict Behav. 2017 Feb;65:296-301
pubmed: 27569697
J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1272-80
pubmed: 24290460
Int J Drug Policy. 2017 Mar;41:8-13
pubmed: 27988428
Rev Med Chil. 2012 Apr;140(4):447-57
pubmed: 22854690
Drug Alcohol Depend. 2017 Sep 1;178:194-200
pubmed: 28654872
BMC Med. 2017 Jul 31;15(1):143
pubmed: 28756776
Drug Alcohol Depend. 2015 Dec 1;157:83-9
pubmed: 26518254
J Adolesc Health. 2012 Jul;51(1):6-17
pubmed: 22727071
Psychol Med. 2005 Dec;35(12):1747-59
pubmed: 16202187
J Subst Abuse Treat. 1991;8(1-2):53-9
pubmed: 1675692
Curr Addict Rep. 2018 Jun;5(2):120-127
pubmed: 30221120
World Psychiatry. 2017 Feb;16(1):102-104
pubmed: 28127929
Drug Alcohol Depend. 2007 Oct 8;90(2-3):280-7
pubmed: 17544227
Addict Behav. 2014 May;39(5):959-64
pubmed: 24556157
J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):226-233.e4
pubmed: 28219488
J Clin Sleep Med. 2008 Dec 15;4(6):579-85
pubmed: 19110888
J Addict Med. 2013 Jan-Feb;7(1):39-44
pubmed: 23222127
J Adolesc Health. 2017 Mar;60(3):328-332
pubmed: 27998704
Drug Alcohol Depend. 2016 Jun 01;163:55-63
pubmed: 27129621
Annu Rev Public Health. 2015 Mar 18;36:559-74
pubmed: 25581144
Eat Behav. 2002 Summer;3(2):153-65
pubmed: 15001012
Psychol Addict Behav. 2015 Mar;29(1):184-91
pubmed: 25419966
BMC Public Health. 2013 May 24;13:499
pubmed: 23705991
Addict Behav. 2016 Jan;52:8-12
pubmed: 26334560

Auteurs

Alexander S Perlmutter (AS)

Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, USA; Université Paris Descartes UMR1153, Hôpital Hôtel-Dieu, 1 Place du Parvis Notre-Dame, Paris, 75004, France. Electronic address: asp2183@cumc.columbia.edu.

Ariadne E Rivera-Aguirre (AE)

Center for Opioid Epidemiology and Policy, Department of Population Health, New York University School of Medicine, 180 Madison Avenue, New York, NY, 10016, USA; Department of Population Health, New York University School of Medicine, 180 Madison Avenue, New York, NY, 10016, USA.

Pia M Mauro (PM)

Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, USA.

Alvaro Castillo-Carniglia (A)

Department of Population Health, New York University School of Medicine, 180 Madison Avenue, New York, NY, 10016, USA; Society and Health Research Center, Facultad de Humanidades, Universidad Mayor, Badajoz 30, Santiago, Chile.

Nicolás Rodriguez (N)

Research Department, National Service for Prevention and Rehabilitation of Drug and Alcohol Use (SENDA), Agustinas 1235, 9th floor, Santiago, Chile.

Nora Cadenas (N)

Dirección de Epidemiologia, Observatorio Argentino de Drogas, Calle Sarmiento 546, Ciudad Autónoma de Buenos Aires, C1041AAL, Argentina.

Magdalena Cerdá (M)

Center for Opioid Epidemiology and Policy, Department of Population Health, New York University School of Medicine, 180 Madison Avenue, New York, NY, 10016, USA; Department of Population Health, New York University School of Medicine, 180 Madison Avenue, New York, NY, 10016, USA.

Silvia S Martins (SS)

Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY, 10032, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH